For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients’ T cells, re-engineering them to recognize tumor antigens, and infusing them back into the body, physicians have achieved effective treatments for leukemia and lymphoma cancers.
This post was originally published on this site